Back to the main directory
Press Release
- Upgrade of earnings expectations for 2021 by GlobeNewsWire
- Ultimovacs Receives Dual FDA Fast Track Designation for UV1 in Advanced Malignant Melanoma by GlobeNewsWire
- DGAP-News: Intershop reports growing cloud business and continued profitable performance in the first nine months of 2021 by EQS Group AG
- Savosolar Oyj – Johdon liiketoimet, Ari Virtanen, lokakuu 2021 by GlobeNewsWire
- VINCI awarded contract for construction of student accommodation in Bristol, Great Britain by GlobeNewsWire
- Savosolar Plc – Managers’ Transaction, Mikael Lemström, October 2021 by GlobeNewsWire
- Savosolar Plc – Managers’ Transaction, Eero Auranne, October 2021 by GlobeNewsWire
- Reliq Health Technologies, Inc. Announces New Contracts with Four US Physician Practices, Adding over 2,000 New Patients by GlobeNewsWire
- DGAP-News: NanoRepro AG und Viromed Medical GmbH unterzeichnen exklusive Vertriebsvereinbarung mit österreichischem Partner by EQS Group AG
- DGAP-News: Mensch und Maschine Software SE presenting Q3 report 2021 by EQS Group AG
- Form 8.5 (EPT/RI) - Sumo Group plc by GlobeNewsWire
- DGAP-News: Vara Research GmbH: Vara Q3 2021 Consensus Estimates for Royal Dutch Shell plc (RDSB LN) by EQS Group AG
- Advantest Issues Call for Papers for VOICE 2022 Developer Conference in Scottsdale, Arizona by GlobeNewsWire
- NAV Update by GlobeNewsWire
- Marel: 3F 2021 Fjárfestakynning by GlobeNewsWire
- Blue Vision A/S - information om bestyrelseskandidat by GlobeNewsWire
- Form 8.3 - Stagecoach Group plc by GlobeNewsWire
- DGAP-News: G&P GmbH & Co. KG / Rechtsanwalt Alexander Elsmann: SolarWorld AG (WKN: A1YCN1 / WKN: A1YDDX) - Verwertung der Aktien an der Zinnwald Lithium PLC by EQS Group AG
- DGAP-News: InCity Immobilien AG: INCITY LAYS FOUNDATION STONE FOR OFFICE SCHEME AT LILIENTHAL BUSINESS CITY NEAR BERLIN AIRPORT by EQS Group AG
- REITIR: Útgáfa á nýjum skuldabréfaflokki REITIR150528 by GlobeNewsWire
- DGAP-News: Sangui BioTech International Inc.: Granulox is awarded the prestigious Prix Galien by EQS Group AG
- Sio Gene Therapies Announces Positive Interim Safety and Biomarker Data from Ongoing Phase 1/2 Clinical Study of AXO-AAV-GM1 Gene Therapy in GM1 Gangliosidosis by GlobeNewsWire
- Kitron: Attachment to previous notification of allocation of options to primary insiders by GlobeNewsWire
- Vistin Pharma ASA: Invitation to Q3 2021 conference call by GlobeNewsWire
- Tri Pointe Homes, Inc. Reports 2021 Third Quarter Results by GlobeNewsWire